糖尿病失脂症和治疗方法的当前前前景
1Cukurova University, Faculty of Medicine, Division of Endocrinology, Adana, Turkey.
Current medicinal chemistry
|January 15, 2025
概括
糖尿病失脂症增加了动脉样硬化风险. 管理涉及他类药物,PCSK-9抑制剂和新药,以SCORE2-糖尿病为指导,以减少心血管并发症.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病 (DM) 与由于失脂血症增加的动脉样硬化风险有关.
- 糖尿病性失脂症,虽然与高脂症有关,但具有不同的特征.
研究的目的:
- 在糖尿病患者中探索超脂血症/脱脂血症机制.
- 审查当前和新型低脂性药物治疗方法.
- 重新评估糖尿病失脂症的管理指南.
主要方法:
- 进行了关于糖尿病,脱脂症和相关术语的综合文献搜索.
- 包括关键词如胰岛素抵抗,心血管疾病和特定药物类 (他类药物,PCSK-9抑制剂,纤维化物).
- 专注于支持治疗策略和指导方针建议的证据.
主要成果:
- 糖尿病性脂质失调症 (低HDL,高甘油三,小密度的LDL) 增加了微/宏血管并发症的风险.
- 建议使用SCORE2-糖尿病评分系统进行风险评估.
- 类药物仍然是糖尿病失脂症患者的LDL降低的主要治疗方法.
结论:
- 糖尿病患者的最佳脂质管理具有挑战性,但对于降低心血管风险至关重要.
- 新兴的疗法,如PCSK-9抑制剂,贝佩多酸和英克利西兰,是治疗方案的重要补充.
- 目前的指导方针强调积极的LDL降低和风险分层.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
526
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
526
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Cholesterol: Significance and Regulation
499
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
499
Overview of Lipid Metabolism
997
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
997


